Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Briacell Therapeutics Corp WT (BCTXW)

Briacell Therapeutics Corp WT (BCTXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Therapeutics Announces Proposed Public Offering

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)
BriaCell Provides Update to its Board of Directors

BCT.TO : 0.83 (-2.35%)
BCTXW : 0.2828 (+6.80%)
BCTX : 0.5610 (-4.12%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar